# Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus

> **NCT04153591** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 75 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04153591
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-05
- **Primary completion:** 2020-06-22
- **Final completion:** 2020-06-22
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2021-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04153591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04153591, "Efficacy and Safety of Direct Oral Anticoagulants for the Treatment of Mural Thrombus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04153591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*